In summary, inhibition of components of the PI3K/Akt/GSK3/mTOR in EGFR-overexpressing MDA-MB 468 breast cancer and HCT8 colon cancer cell lines is associated with inhibitor-specific changes in PCho content. This evidence concerns the gene AKT1 and breast cancer.